One-Year Efficacy and Safety of Rosuvastatin + Fenofibric Acid Combination Therapy in Patients with Mixed Dyslipidemia.

MLA

Ferdinand, Keith C., et al. “One-Year Efficacy and Safety of Rosuvastatin + Fenofibric Acid Combination Therapy in Patients with Mixed Dyslipidemia.” American Journal of Cardiovascular Drugs, vol. 12, no. 2, Mar. 2012, pp. 117–25. EBSCOhost, https://doi.org/10.2165/11597940-000000000-00000.

APA

Ferdinand, K. C., Davidson, M. H., Kelly, M. T., & Setze, C. M. (2012). One-Year Efficacy and Safety of Rosuvastatin + Fenofibric Acid Combination Therapy in Patients with Mixed Dyslipidemia. American Journal of Cardiovascular Drugs, 12(2), 117–125. https://doi.org/10.2165/11597940-000000000-00000

Chicago

Ferdinand, Keith C., Michael H. Davidson, Maureen T. Kelly, and Carolyn M. Setze. 2012. “One-Year Efficacy and Safety of Rosuvastatin + Fenofibric Acid Combination Therapy in Patients with Mixed Dyslipidemia.” American Journal of Cardiovascular Drugs 12 (2): 117–25. doi:10.2165/11597940-000000000-00000.